11 research outputs found
Correlation of tumor markers p53, bcl-2 and cathepsin-D with clinicopathologic features and disease-free survival in laryngeal squamous cell carcinoma
Various recognized prognostic factors in squamous cell carcinoma (SCC)
of the larynx influence the therapeutic options offered to an individual
patient in order to extend the survival expectancy. Additional
prognostic indicators are required in specific patient subgroups. The
present study used a standard immunohistochemical technique in order to
retrospectively evaluate the accumulation of p53 gene product and the
immunoreactivity of bcl-2 protein and cathepsin-D as possible prognostic
markers of laryngeal SCC. Formalin-fixed, paraffin-embedded tumor
materials were obtained from a series of 64 patients with cancer of the
larynx. Immunostaining was evaluated by computerized image analysis. The
accumulation of p53 protein was found in 57.8% (37/64) of the patients
and was associated with large tumor size. The percentage of p53-positive
neoplastic cells increased in high-grade carcinomas, particularly when
they simultaneously demonstrated cathepsin-D immunoreaction in stromal
cells (P = 0.049); bcl-2 immunoexpression was found to be generally
limited. Cathepsin-D immunostaining was observed in tumor parenchymal
and stromal cells (31.25% and 37.5% of all cases, respectively); it
was found to be useful in defining patient subgroups with differences in
relapse-free survival. Among patients with positive lymph nodes, those
with cathepsin-D immunopositive tumor cells were at higher risk for
relapsing (P = 0.0395). Although the classical prognostic factors of
laryngeal carcinoma retain their predominance, cathepsin-D
immunoreactivity may serve as an additional prognosticator in specific
patient subgroups
Cyclin D1 protein tissue detection in laryngeal cancer
Cyclin D1 (CCND1) is a set of periodic regulatory proteins that is
believed to govern cell cycle transit from G1 into S phase.
Overexpression of CCND1 leads to abnormal cellular proliferation which
underlies processes of tumorigenesis; CCND1 can thus function as a
cooperative oncogene in cell transformation. In the present study we
investigate the immunohistochemical expression of CCND1 in a
well-documented series of 58 laryngeal squamous cell carcinomas (LSCC)
and search for statistical associations between CCND1 index and various
clinicopathological parameters including several immunomarkers’
expression as well as patients’ disease-free survival. Tissue sections
from archival paraffin blocks were stained using the
avidin-biotin-peroxidase complex method; the H-295 rabbit polyclonal
antibody was applied at dilution of 1: 150. The percentage of CCND1
immunoreactive tumor cells for each tumor was counted by an image
analysis system. CCND1 staining was confined to cell nuclei and, in the
examined samples, ranged from undetectable (i.e. 0% of tumor cells, n =
6) to the majority of tumor cells (i.e. 89% of tumor cells) with mean
value: 15.73%. In tumor adjacent, non invasive lesions, strong CCND1
staining was noticed in areas with cellular atypia. In cases with nodal
metastases, no change in CCND1 expression in the nodal metastases
compared with the primary tumors was observed. p53 protein accumulation
in malignant cells was positively linked with CCND1 index (Mann-Whitney
U: 205.5, p = 0.034). CCND1 expression appears to be an early event in
processes of tumorigenesis and tumor progression in some LSCC. Apart
from p53 protein accumulation, CCND1 immunohistochemical expression does
not seem to correlate with nodal metastasis, disease recurrence or any
other clinicopathological prognostic indicator. Copyright (C) 2005 S.
Karger AG, Basel
Scriptural citation in Andronikos Kamateros
La citazione biblica come strumento retorico